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Background: For patients with uncertain exercise capacity, dipyridamole plus symptom-limited exercise (Dip-Ex) with myocardial perfusion 
imaging (MPI) is a safe and useful test. Unlike dipyridamole, regadenoson (Lexiscan®) has rapid action and thus could be injected during symptom-
limited exercise (Ex-Lex) when exercise is deemed suboptimal, enhancing laboratory efficiency and resource utilization.
Methods:  Patients referred for vasodilator/exercise MPI were randomized 2:1 to Ex-Lex or Dip-Ex. Hemodynamics were recorded during Bruce exercise 
and vasodilator stress. Patients completed a symptom questionnaire immediately after stress testing. MPI image quality was assessed by blinded read.
Results: Forty three patients (mean age 62, 46% male) with perceived exercise limitations were randomized (12 to Dip-Ex and 31 to Ex-Lex). Among Ex-
Lex patients, 48% exercised to goal heart rate and did not require regadenoson. Overall stress protocol time was shorter with Ex-Lex (12.5 minutes) than 
with Dip-Ex (16.2 minutes). Symptoms and side effects were similar between groups. There were no serious adverse events with regadenoson injection 
during exercise. MPI image quality was “excellent” or “good” in all patients. Interpretive certainty was similar between stress protocols.
Conclusion: Symptom-limited exercise followed by regadenoson injection, as necessary, is a safe and well-tolerated stress protocol and results in 
optimal MPI quality for interpretation while minimizing pharmaceutical use. 
Table. Exercise, Symptom, and Nuclear Image Quality Data
All Ex-Lex
patients
n=31
Exercise/No Lexiscan n=15
Ex-Lex
n=16
Dip-Ex
n=12
Exercise Parameters
Exercise time (mean) 6.1 minutes 6.4 minutes 5.9 minutes 4.5 minutes
Peak RPP (mean) 19,139 22,952 15,566 17,295
METs 6.9 7.6 6.2 5.6
% of patients reaching ≥85% age-predicted maximum heart rate 48% 100% 0% 0%
Overall test time (mean) 12.5 minutes 12.5 minutes 12.5 minutes 16.2 minutes
Patient-reported symptoms
Dyspnea or Chest Discomfort
(moderate or severe)
12 (39%) 3 (20%) 9 (56%) 4 (33%)
Headache, Flushing, Dizziness, or Nausea (moderate or severe) 5 (16%) 0 5 (31%) 4 (33%)
Overall comfort level during test
“Comfortable” or “A little uncomfortable” 28 (90%) 13 (87%) 15 (94%) 10 (83%)
“Very uncomfortable” or “Extremely uncomfortable” 3 (10%) 2 (13%) 1 (6%) 2 (17%)
Stress MPI Image Quality: Assessed as Excellent, Good, Fair, or Poor
Excellent or Good 30/30* 15/15 15/15* 12/12
Interpretive Certainty of Blinded Read
Definitely normal or abnormal 28 14 14 11
Probably normal or abnormal 2 0 1 1
Equivocal 0 0 0 0
*MPI unavailable for assessment in one patient for technical reasons. 
